Status:
COMPLETED
Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes
Lead Sponsor:
Alexion Pharmaceuticals, Inc.
Conditions:
Hemoglobinuria
Eligibility:
All Genders
10+ years
Brief Summary
Examine red and white blood cells of PNH patients with bone marrow failure syndromes.
Eligibility Criteria
Inclusion
- At least 10 years of age.
- Has aplastic anemia, myelodysplastic syndromes or other bone marrow failure syndromes
Exclusion
- Has any condition that might interfere with the patient's participation
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
5580 Patients enrolled
Trial Details
Trial ID
NCT01192425
Last Update
September 1 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.